MCKENNA BLYLY: Open Payments
NPI 1568094308 · BATTLE CREEK, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,208 in 53 payments from 25 companies in 2025. Trend: 2023 $1,127 · 2024 $500 · 2025 $1,208
Food & beverage: $1,010Education: $198
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 16 | $230 |
| Astellas Pharma US Inc | 3 | $148 |
| Incyte Corporation | 3 | $116 |
| PFIZER INC. | 3 | $62 |
| Eisai Inc. | 2 | $61 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $58 |
| Merck Sharp & Dohme LLC | 2 | $55 |
| TerSera Therapeutics LLC | 2 | $50 |
| Janssen Biotech, Inc. | 2 | $49 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
Products named: KISQALI, Lenvima, Zoladex, IBRANCE, SCEMBLIX, JAKAFI, CALQUENCE, LYNPARZA.
Industry payments across MI — which companies pay providers there.
